Source link : https://www.newshealth.biz/health-news/bimekizumab-lowers-uveitis-rates-in-axial-spondyloarthritis/
TOPLINE: Patients with axial spondyloarthritis (axSpA) treated with bimekizumab had a lower incidence of uveitis than those receiving placebo in pooled clinical trial data. METHODOLOGY: Researchers pooled data from two phase 3 trials, one phase 2b trial, and their open-label extensions to evaluate the incidence of uveitis in patients with radiographic and nonradiographic axSpA who […]
Author : News Health
Publish date : 2024-08-27 06:30:34
Copyright for syndicated content belongs to the linked Source.
Categories